[go: up one dir, main page]

MXPA06001821A - Una composicion probiotica, liquida, estable, preparacion y aplicaciones de la misma. - Google Patents

Una composicion probiotica, liquida, estable, preparacion y aplicaciones de la misma.

Info

Publication number
MXPA06001821A
MXPA06001821A MXPA06001821A MXPA06001821A MXPA06001821A MX PA06001821 A MXPA06001821 A MX PA06001821A MX PA06001821 A MXPA06001821 A MX PA06001821A MX PA06001821 A MXPA06001821 A MX PA06001821A MX PA06001821 A MXPA06001821 A MX PA06001821A
Authority
MX
Mexico
Prior art keywords
bacteria
probiotic composition
applications
preparation
substances
Prior art date
Application number
MXPA06001821A
Other languages
English (en)
Inventor
Nellie Kelner-Padalka
Original Assignee
Bio Balance Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Balance Corp filed Critical Bio Balance Corp
Publication of MXPA06001821A publication Critical patent/MXPA06001821A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

Un metodo para preparar una composicion probiotica liquida, que comprende bacterias que tienen por lo menos una actividad biologica basal, en donde las bacterias han sido seleccionadas de acuerdo a por lo menos una presion de seleccion, en donde la composicion preferiblemente incluye un autolisato (sustancias completas para mantener a las bacterias) y en donde la composicion esta sustancialmente libre de sustancias adecuadas para el crecimiento bacteriano pero no similarmente adecuadas para mamiferos, y particularmente no adecuadas para seres humanos. Peptona y sales amortiguadoras, particularmente fosfatos, pueden no ser daninas en dosis pequenas, pero las mismas no son especificamente adecuadas para seres humanos y libres de sustancias generadas por las bacterias.
MXPA06001821A 2003-08-18 2004-08-16 Una composicion probiotica, liquida, estable, preparacion y aplicaciones de la misma. MXPA06001821A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49571403P 2003-08-18 2003-08-18
PCT/IL2004/000749 WO2005017095A2 (en) 2003-08-18 2004-08-16 A stable liquid probiotic composition, preparation and applications thereof

Publications (1)

Publication Number Publication Date
MXPA06001821A true MXPA06001821A (es) 2006-05-31

Family

ID=34193337

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06001821A MXPA06001821A (es) 2003-08-18 2004-08-16 Una composicion probiotica, liquida, estable, preparacion y aplicaciones de la misma.

Country Status (12)

Country Link
US (1) US20050042207A1 (es)
EP (1) EP1656025A4 (es)
JP (1) JP2007518693A (es)
KR (1) KR20060073937A (es)
CN (1) CN1867258A (es)
AU (1) AU2004265511A1 (es)
BR (1) BRPI0412979A (es)
CA (1) CA2535892A1 (es)
MX (1) MXPA06001821A (es)
RU (1) RU2006108554A (es)
WO (1) WO2005017095A2 (es)
ZA (1) ZA200601391B (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
EP1667649A4 (en) * 2003-10-02 2011-07-06 Bio Balance Corp DRIED BIOTHERAPEUTIC COMPOSITION, USES AND DEVICE AND METHOD OF ADMINISTRATION
US20070009490A1 (en) * 2003-10-02 2007-01-11 Conte Anthony E Dried biotherapeutic composition, uses, and device and methods for administration thereof
MY143693A (en) 2004-03-24 2011-06-30 Nestec Sa Shelf stable product wih living micro-organisms
FR2901138A1 (fr) * 2006-05-19 2007-11-23 Lesaffre & Cie Compositions de micro-organismes probiotiques, granules les contenant, leur procede de preparation et leurs utilisations
DK2114421T3 (en) * 2007-03-05 2018-04-23 Om Pharma BACTERIA EXTRACTS FOR RESPIRATORY DISORDERS AND PROCEDURES FOR PREPARING THEREOF
EP3424515A3 (en) 2010-08-04 2019-06-19 Thomas Julius Borody Stool collection devices and methods for using them
WO2012118535A1 (en) * 2011-03-01 2012-09-07 Quorum Innovations, Llc Materials and methods for treating conditions associated with pathogenic biofilm
EP2683390B1 (en) 2011-03-09 2017-05-03 Regents Of The University Of Minnesota Compositions and methods for transplantation of colon microbiota
US9719144B2 (en) 2012-05-25 2017-08-01 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
RU2513204C1 (ru) * 2012-11-22 2014-04-20 Федеральное бюджетное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека Способ получения комбинированного антибактериального препарата для лечения острых кишечных инфекций
RU2504388C1 (ru) * 2012-11-22 2014-01-20 Федеральное бюджетное учреждение науки "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека Комбинированный антибактериальный препарат для лечения острых кишечных инфекций
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
PL3628161T3 (pl) * 2012-11-23 2023-08-07 Seres Therapeutics, Inc. Synergistyczne kompozycje bakteryjne i sposoby ich wytwarzania oraz stosowanie
EP3904502A3 (en) 2013-02-04 2022-02-23 Seres Therapeutics, Inc. Compositions and methods
HK1219022A1 (zh) 2013-02-04 2017-03-24 Seres Therapeutics, Inc. 填充胃肠道的方法
US10076546B2 (en) 2013-03-15 2018-09-18 Seres Therapeutics, Inc. Network-based microbial compositions and methods
WO2015077794A1 (en) 2013-11-25 2015-05-28 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
EP3082431A4 (en) 2013-12-16 2017-11-15 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
HK1252460A1 (zh) 2015-05-14 2019-05-24 Crestovo Holdings Llc 用於糞便菌群移植的組合物以及用於製備和使用它們的方法和用於遞送它們的裝置
PT3297644T (pt) 2015-05-22 2022-03-30 Univ Arizona State Métodos para tratar distúrbios do espetro do autismo e sintomas associados
AU2017208849B2 (en) 2016-01-19 2021-06-10 Synergia Life Sciences Pvt. Ltd A liquid probiotic composition stable at ambient temperature
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
WO2018026604A1 (en) * 2016-08-01 2018-02-08 Scaled Microbiomics, Llc Systems and methods for altering microbiome to reduce disease risk and manifestations of disease
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11213549B2 (en) 2016-10-11 2022-01-04 Finch Therapeutics Holdings Llc Compositions and method for treating primary sclerosing cholangitis and related disorders
CA3058818A1 (en) 2017-04-05 2018-10-11 Crestovo Holdings Llc Compositions and methods for treating parkinson's disease (pd) and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
JP2020521760A (ja) 2017-05-26 2020-07-27 クレストヴォ・ホールディングス・エルエルシー 糞便微生物ベースの治療剤を含む凍結乾燥組成物ならびにそれを製造および使用する方法
CN111328284A (zh) 2017-08-07 2020-06-23 芬奇治疗公司 用于维持和恢复健康的肠道屏障的组合物和方法
CA3072206A1 (en) 2017-08-14 2019-02-21 Seres Therapeutics, Inc. Compositions and methods for treating cholestatic disease
BR112020008552A2 (pt) 2017-10-30 2020-12-29 Seres Therapeutics, Inc. métodos e composições para tratamento de resistência a antibiótico
WO2019168034A1 (ja) * 2018-02-28 2019-09-06 腸内フローラ移植臨床研究株式会社 生体微生物含有組成物及びその製造方法
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
CA3114423A1 (en) 2018-09-27 2020-04-02 Finch Therapeutics Holdings Llc Compositions and methods for treating epilepsy and related disorders
WO2021016081A1 (en) 2019-07-19 2021-01-28 Finch Therapeutics Holdings Llc. Methods and products for treatment of gastrointestinal disorders
WO2021159068A1 (en) * 2020-02-06 2021-08-12 Nch Corportion Composition and method of using germinative compounds in probiotics for inflammation reduction in humans

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518696A (en) * 1983-01-11 1985-05-21 Chr. Hansen's Laboratory, Inc. Stabilized liquid bacterial suspension for oral administration to animals
GB8700354D0 (en) * 1987-01-08 1987-02-11 Distillers Co Culture of micro-organisms
US4910024A (en) * 1988-07-05 1990-03-20 Micro Chemical, Inc. Method and apparatus for administering live bacteria as feed additives to livestock and poultry
US5443826A (en) * 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
US5139792A (en) * 1990-07-19 1992-08-18 Bio-Techniques Laboratories, Inc. Method and system for dispensing live bacteria into animal feed and drinking water
GB9107305D0 (en) * 1991-04-08 1991-05-22 Unilever Plc Probiotic
US5501857A (en) * 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
US5340577A (en) * 1992-07-29 1994-08-23 The United States Of America, As Represented By The Secretary Of Agriculture Probiotic for control of salmonella
US5478557A (en) * 1992-07-29 1995-12-26 The United States Of America, As Represented By The Secretary Of Agriculture Probiotic for control of salmonella
US5840318A (en) * 1993-05-11 1998-11-24 Immunom Technologies, Inc. Methods and compositions for modulating immune systems of animals
US5733568A (en) * 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
DE19751907B4 (de) * 1997-11-22 2004-07-08 Pharma-Zentrale Gmbh Verwendung von Escherichia coli Stamm DSM 6601 zur Behandlung von Diarrhoeen auf dem Veterinärsektor
US6706287B2 (en) * 2001-05-15 2004-03-16 Kibow Biotech Inc. Prebiotic and probiotic compositions and methods for their use in gut-based therapies
IL130303A0 (en) * 1999-06-03 2000-06-01 M G Novobiotech Ltd A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use
KR20030082549A (ko) * 2000-11-30 2003-10-22 더 바이오 밸런스 코포레이션 박테리아 균주, 처리된 식물 추출물, 이를 함유하는조성물, 이의 제조방법 및 치료적 용도 및 산업적 용도
JP4671384B2 (ja) * 2001-05-15 2011-04-13 雪印乳業株式会社 新規乳酸菌株
RU2253672C2 (ru) * 2002-07-12 2005-06-10 Хачатрян Ашот Папикович Бактериальный пробиотический препарат
ITBO20020564A1 (it) * 2002-09-06 2004-03-07 Alfa Wassermann Spa Bifidobatteri e preparazioni che li contengono.
IL152127A0 (en) * 2002-10-06 2003-05-29 Bio Balance Corp Probiotic compositions for the treatment of inflammatory bowel disease

Also Published As

Publication number Publication date
EP1656025A4 (en) 2007-12-05
AU2004265511A1 (en) 2005-02-24
CN1867258A (zh) 2006-11-22
WO2005017095A3 (en) 2005-07-07
US20050042207A1 (en) 2005-02-24
RU2006108554A (ru) 2007-09-27
BRPI0412979A (pt) 2006-10-03
WO2005017095A2 (en) 2005-02-24
ZA200601391B (en) 2007-04-25
CA2535892A1 (en) 2005-02-24
EP1656025A2 (en) 2006-05-17
JP2007518693A (ja) 2007-07-12
KR20060073937A (ko) 2006-06-29

Similar Documents

Publication Publication Date Title
MXPA06001821A (es) Una composicion probiotica, liquida, estable, preparacion y aplicaciones de la misma.
AU2003212265A1 (en) Dietetic and/or pharmaceutical compositions for human and/or animal use based on probiotic microbial preparations
EP1567660A4 (en) Merging fermented ginseng, lactose, yoghurt, and lactose used in the production of milk lactobacteria
EP1670450B8 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
MX336500B (es) Insecticida para uso agricola u horticola y metodo para su uso.
NZ593794A (en) Bacterial vaccines with cell wall-associated ceramide-like glycolipids and uses thereof
MXPA05006350A (es) Composicion de medio de cultivo, procedimiento de cultivo y mioblastos obtenidos y sus utilizaciones.
AU6901501A (en) Non-viable lactobacillus containing food product
PL1644481T3 (pl) Zastosowanie związków włączonych w biosyntezę kwasów nukleinowych jako czynników krioochronnych
SI1753440T1 (sl) Oralna oblika, vsebujoäśa probiotiäśne bakterije
ZA200900164B (en) Cysteine granules and use thereof as bifidobacterium animals lactis growth stimulants
WO2006065139A3 (en) Deacylation of lps in gram negative bacteria
MY139935A (en) Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
EP2275530A3 (de) Verfahren zur Kultivierung von Zellen zur Produktion von Substanzen
GB0203307D0 (en) Method
WO2004089964A8 (ja) 脂質調節剤及びその用途
AU2001281880A1 (en) Use of a formulation made of or containing at least one dissimilated milk serum
DE60324948D1 (de) Herstellungsverfahren für iturin a und dessen homologe
MX2008009645A (es) Adhesivo medico y metodos de adhesion de tejidos.
NZ516810A (en) Method of forming an artificial shiro of tricholoma matsutake hyphae
AU2003290053A1 (en) Process for the fermentative preparation of l-amino acids using strains of the enterobacteriaceae family which contain an attenuated yjgf orf sequence
DE602004008051D1 (de) Aus einer bifidobakterien-kultur gewonnener immunomodulator und diesen enthaltende zusammensetzungen
EP1172434A4 (en) VIOLET PHOTOSYNTHETIC BACTERIA AND DIET FOOD
TW200630357A (en) N-heterocyclylphthaldiamides
TW200505482A (en) Lklf/klf2 gene expression promoters

Legal Events

Date Code Title Description
FA Abandonment or withdrawal